| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9327301 | Gynecologic Oncology | 2005 | 5 Pages |
Abstract
The hematological toxicity was the main factor limiting administration of cisplatin at 50 mg/m2 in weeks 1 and 4 and weekly paclitaxel at 50 mg/m2 in weeks 1-5 concomitantly with extended field radiotherapy of locally advanced cervical carcinoma.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
JiÅà Petera, Karel Odrážka, TomáÅ¡ Frgala, JiÅà ŠpaÄek,